REFERENCES
1. Siegel RL, Miller KD, Goding Sauer A, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020;70:145-64.
2. Dekker E, Tanis PJ, Vleugels JLA, Kasi PM, Wallace MB. Colorectal cancer. Lancet. 2019;394:1467-80.
3. Tao Y, Li J, Pan J, et al. Integration of scRNA-seq and bulk RNA-Seq identifies circadian rhythm disruption-related genes associated with prognosis and drug resistance in colorectal cancer patients. Immunotargets Ther. 2025;14:475-89.
4. Guinney J, Dienstmann R, Wang X, et al. The consensus molecular subtypes of colorectal cancer. Nat Med. 2015;21:1350-6.
5. Wang X, Wei W, Hua N, Li C, Yu L. Diagnostic value of serum fibrin degradation complex DR-70 combined with conventional tumor biomarkers in colorectal cancer. J Int Med Res. 2024;52:3000605241266236.
6. Osseis M, Nehmeh WA, Rassy N, et al. Surgery for T4 colorectal cancer in older patients: determinants of outcomes. J Pers Med. 2022;12:1534.
7. Kalyan A, Kircher S, Shah H, Mulcahy M, Benson A. Updates on immunotherapy for colorectal cancer. J Gastrointest Oncol. 2018;9:160-9.
8. Chen Y, Xiao C, Fan Q, Zhang Y, Huang Q, Ou Y. Multi-omics pan-cancer analysis of procollagen N-propeptidase gene family of ADAMTS as novel biomarkers to associate with prognosis, tumor immune microenvironment, signaling pathways, and drug sensitivities. Front Biosci. 2024;29:151.
9. Xie J, Xie Y, Tan W, et al. Deciphering the role of ELAVL1: insights from pan-cancer multiomics analyses with emphasis on nasopharyngeal carcinoma. J Transl Int Med. 2025;13:138-55.
10. Bai R, Wu D, Shi Z, et al. Pan-cancer analyses demonstrate that ANKRD6 is associated with a poor prognosis and correlates with M2 macrophage infiltration in colon cancer. Chin J Cancer Res. 2021;33:93-102.
11. Zheng P, Yang S, Ren D, Zhang X, Bai Q. A pan-cancer analysis of the oncogenic role of methyltransferase-like 1 in human tumors. Neurol India. 2024;72:837-45.
12. Elizazu J, Artetxe-Zurutuza A, Otaegi-Ugartemendia M, et al. Identification of a novel gene signature related to prognosis and metastasis in gastric cancer. Cell Oncol. 2024;47:1355-73.
13. Nie K, He ZJ, Kong LJ. NR3C2 affects the proliferation and invasiveness of colon cancer cells through the Wnt/β-Catenin signaling pathway. J Cancer Res Clin Oncol. 2024;150:411.
14. Tian J, Cao X, Jiang Z, et al. LncRNA CCAT2 promotes the proliferation and metastasis of colorectal cancer through activation of the ERK and Wnt signaling pathways by regulating GNB2 expression. Cancer Med. 2024;13:e70169.
15. Zhao H, Liu G, Li Y, Yang N, Zhao J. [High expression of ANKRD6 is an indicator for poor prognosis of colon adenocarcinoma]. Nan Fang Yi Ke Da Xue Xue Bao. 2023;43:1715-24.
16. Liu S, Lv S, Li X, Lu W, Chen S. The signature genes of cuproptosis associates with tumor immune microenvironment and predicts prognosis in kidney renal clear cell carcinoma. Front Oncol. 2024;14:1409620.
17. Zhao Z, Song Z, Wang Z, et al. Retinol dehydrogenase 10 promotes epithelial-mesenchymal transition in spinal cord gliomas via PI3K/AKT pathway. Int J Immunopathol Pharmacol. 2024;38:3946320241276336.
18. Lin X, Zheng J, Cai X, et al. Glycometabolism and lipid metabolism related genes predict the prognosis of endometrial carcinoma and their effects on tumor cells. BMC Cancer. 2024;24:571.
19. Malta TM, Sokolov A, Gentles AJ, et al. Machine learning identifies stemness features associated with oncogenic dedifferentiation. Cell. 2018;173:338-54.e15.
20. Xun Z, Ding X, Zhang Y, et al. Reconstruction of the tumor spatial microenvironment along the malignant-boundary-nonmalignant axis. Nat Commun. 2023;14:933.
21. Shi J, Wei X, Xun Z, et al. The web-based portal SpatialTME integrates histological images with single-cell and spatial transcriptomics to explore the tumor microenvironment. Cancer Res. 2024;84:1210-20.
22. Varghese F, Bukhari AB, Malhotra R, De A. IHC profiler: an open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples. PLoS One. 2014;9:e96801.
23. Jung I, An J, Ko M. Epigenetic regulators of DNA cytosine modification: promising targets for cancer therapy. Biomedicines. 2023;11:654.
24. Yang Q, Jiang W, Hou P. Emerging role of PI3K/AKT in tumor-related epigenetic regulation. Semin Cancer Biol. 2019;59:112-24.
25. Weng J, Lin J, Xie Y, et al. Abstract 6006: RNA m6A methylation relay the oncogenic flow from DNA methylationto gene expression of ANKRD13B. Cancer Res. 2023;83:6006.
26. He CM, Zhang XD, Zhu SX, et al. Integrative pan-cancer analysis and clinical characterization of the N7-methylguanosine (m7G) RNA modification regulators in human cancers. Front Genet. 2022;13:998147.
27. Cirone P, Lin S, Griesbach HL, Zhang Y, Slusarski DC, Crews CM. A role for planar cell polarity signaling in angiogenesis. Angiogenesis. 2008;11:347-60.
29. Schwarz-Romond T, Asbrand C, Bakkers J, et al. The ankyrin repeat protein Diversin recruits Casein kinase Iepsilon to the beta-catenin degradation complex and acts in both canonical Wnt and Wnt/JNK signaling. Genes Dev. 2002;16:2073-84.
30. Qiong L, Shuyao X, Shan X, et al. Recent advances in the glycolytic processes linked to tumor metastasis. Curr Mol Pharmacol. 2024;17:e18761429308361.
31. Karati D, Kumar D. Molecular insight into the apoptotic mechanism of cancer cells: an explicative review. Curr Mol Pharmacol. 2024;17:e18761429273223.
32. Yin CL, Ma YJ. The regulatory mechanism of hypoxia-inducible factor 1 and its clinical significance. Curr Mol Pharmacol. 2024;17:e18761429266116.
33. Sensi B, Angelico R, Toti L, et al. Mechanism, potential, and concerns of immunotherapy for hepatocellular carcinoma and liver transplantation. Curr Mol Pharmacol. 2024;17:e18761429310703.
34. Chen JS, Huang JQ, Luo B, et al. PIK3CD induces cell growth and invasion by activating AKT/GSK-3β/β-catenin signaling in colorectal cancer. Cancer Sci. 2019;110:997-1011.
35. Bai J, Zhang X, Xiang ZX, Zhong PY, Xiong B. Identification of prognostic immune-related signature predicting the overall survival for colorectal cancer. Eur Rev Med Pharmacol Sci. 2020;24:1134-41.
36. Zhou L, Yu Y, Wen R, et al. Development and validation of an 8-gene signature to improve survival prediction of colorectal cancer. Front Oncol. 2022;12:863094.
37. Cai Z, Zhou F. A novel Anoikis and immune-related genes marked prognostic signature for colorectal cancer. Medicine. 2022;101:e31127.
38. Chen Z, Chen M, Xue Z, Zhu X. Comprehensive analysis of gene expression profiles identifies a P4HA1-related gene panel as a prognostic model in colorectal cancer patients. Cancer Biother Radiopharm. 2021;36:693-704.
39. Faleiro I, Roberto VP, Demirkol Canli S, et al. DNA methylation of PI3K/AKT pathway-related genes predicts outcome in patients with pancreatic cancer: a comprehensive bioinformatics-based study. Cancers. 2021;13:6354.
40. Zhao Q, Zhao Y, Hu W, et al. m6A RNA modification modulates PI3K/Akt/mTOR signal pathway in Gastrointestinal Cancer. Theranostics. 2020;10:9528-43.
41. Tsuruta N, Tsuchihashi K, Ohmura H, et al. RNA N6-methyladenosine demethylase FTO regulates PD-L1 expression in colon cancer cells. Biochem Biophys Res Commun. 2020;530:235-9.
42. Niu Y, Lin Z, Wan A, et al. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3. Mol Cancer. 2019;18:46.
43. Ma YS, Li W, Liu Y, Shi Y, Lin QL, Fu D. Targeting colorectal cancer stem cells as an effective treatment for colorectal cancer. Technol Cancer Res Treat. 2020;19:1533033819892261.
44. Li N, Babaei-Jadidi R, Lorenzi F, et al. An FBXW7-ZEB2 axis links EMT and tumour microenvironment to promote colorectal cancer stem cells and chemoresistance. Oncogenesis. 2019;8:13.
45. Das PK, Islam F, Lam AK. The roles of cancer stem cells and therapy resistance in colorectal carcinoma. Cells. 2020;9:1392.
46. Li J, Li S, Xing X, et al. FTO-mediated ZNF687 accelerates tumor growth, metastasis, and angiogenesis in colorectal cancer through the Wnt/β-catenin pathway. Biotechnol Appl Biochem. 2024;71:245-55.
47. Zhang H, Xu C, Jiang F, Feng J. A three-genes signature predicting colorectal cancer relapse reveals LEMD1 promoting CRC cells migration by RhoA/ROCK1 signaling pathway. Front Oncol. 2022;12:823696.
49. Aizawa T, Karasawa H, Funayama R, et al. Cancer-associated fibroblasts secrete Wnt2 to promote cancer progression in colorectal cancer. Cancer Med. 2019;8:6370-82.
